Digital Health
Accelerating Drug Development Using Medical Imaging AI
In this GEN webinar, Dr. Shelby Wyatt from Flywheel will discuss how AI-based medical imaging helps imaging/data scientists, innovators, and healthcare…
Broadcast Date: November 7, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Automated analysis of medical imaging data is just one of the ways that artificial intelligence (AI) technologies are transforming the standard of care in medicine. Across industry and academia, scientists are using AI to extract useful patterns from data, improve studies of conditions such as neurological disorders, oncology, and ophthalmology, and increasingly in the context of drug development. There are ample opportunities to leverage AI in the drug development process from discovery and development to the design, conduct, and interpretation of clinical trials. One critical area is the analysis and management of complex clinical information such as medical imaging data, which contains important insights for assessing the effectiveness of treatments.
In this GEN webinar, Dr. Shelby Wyatt will discuss how AI-based medical imaging helps imaging/data scientists, innovators, and healthcare professionals accelerate drug development initiatives and projects and move the needle towards personalized healthcare. She will discuss how Flywheel builds reliable, scalable medical imaging solutions that seamlessly integrate advanced AI technology from NVIDIA and other technology partners to enable robust imaging data management and analysis.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
VP of Global Pharma Strategy
Flywheel.io
Webinar produced with support from:
The post Accelerating Drug Development Using Medical Imaging AI appeared first on GEN – Genetic Engineering and Biotechnology News.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
